Sixty-two medical companies in Ohio have received grants or tax credits through a provision of this year’s health reform law that’s designed to fund the development of new therapies.
The grants come through the $1 billion Qualifying Therapeutic Discovery Project tax credit, which is intended to fund projects that show significant potential to produce new and cost-saving therapies, support good jobs and increase U.S. competitiveness, trade group BioOhio said. (Startups with no tax liability can choose instead to receive a grant.)
The grants max out at $244,000, but some companies pulled in more cash by receiving multiple grants. Big winners included Columbus-based OptimumTherapeutics and Cincinnati-based Akebia Therapeutics, which both received more than $700,000 through the program. Not too shabby for a piece of legislation that some pro-business people regard as “a monstrosity.”
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
For the full list of Ohio recipients (so far), visit BioOhio’s always-informative MicrOHscope blog.